Fig. 2
From: Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case report
Treatment course and blood parameter trends. a Schematic treatment summary. b Peripheral blood eosinophil counts, D-dimer levels, and platelet counts during the clinical course